Federal regulations are currently in effect to ensure adverse events associated with prescription drugs are reported promptly to the U.S. Food and Drug Administration (FDA). However, a new analysis of adverse event reporting has discovered some drug manufacturers may be neglecting those federal guidelines, which could be putting the lives... Read more »

Actos, a type 2 diabetes medication that has been linked in some studies to an increased risk of bladder cancer, is now suspected of raising the risk of other types of cancer as well. In addition to the much publicized Actos side effects to date, emerging research has determined that the... Read more »

Testosterone side effects, such as those reported with topical testosterone products like AndroGel, have raised the concern of many healthcare providers and men in recent months. Now, a new study indicates elevated testosterone levels could increase the risk for another complication. The study found a link between high testosterone levels... Read more »

A plaintiff that filed a Xarelto lawsuit in Georgia alleges use of the drug led to life-threatening bleeding, permanent injury and loss of enjoyment of life. The plaintiff further states that Xarelto manufacturer Janssen Pharmaceuticals, as well as Janssen’s mother company Bayer, failed to provide proper warning about the risks... Read more »

Two women have each filed a Zofran birth defects lawsuit, alleging their children experienced serious defects after the women took the drug to treat morning sickness during their pregnancies. The two lawsuits, filed in Texas and Massachusetts courts, accuse Zofran manufacturer GlaxoSmithKline of failing to reveal risks associated with the drug,... Read more »

Even as popular diabetes drugs like Januvia and Actos continue to come under scrutiny, another diabetes drug has recently made headlines. Concerns over Onglyza heart failure have prompted a review by an FDA panel, which could lead to a label change for this drug and others like it. As “mortality”... Read more »

A class action lawsuit brought against baby powder manufacturer Johnson & Johnson has been dismissed by a federal judge, because allegations by the plaintiff did not include any documented injuries. However, many other baby powder cancer lawsuits are currently pending across the country, filed by women who did indeed suffer... Read more »

A plaintiff and his wife have filed a Byetta cancer lawsuit in California, claiming long time use of the drug to treat type II diabetes led to a thyroid cancer diagnosis. This complaint joins a growing number of Byetta & Januvia lawsuits in coordinated proceedings in the U.S. District Court... Read more »

An Actos class action lawsuit filed in Louisiana will remain separate from coordinated proceedings currently underway in that court, a judge has ruled. U.S. District Judge Rebecca Doherty recently issued an order stating the case filed by a health care fund will remain separate from hundreds of claims currently pending in... Read more »

An investigation by Deborah Cohen of the British Medical Journal (BMJ) has revealed that Pradaxa manufacturer Boehringer Ingelheim may have withheld analyses that might have prevented some Pradaxa bleeding events. Monitoring and dosing adjustments could make use of the drug even safer and more effective, according to Cohen’s findings. However, the... Read more »